efexor depot 150 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
efexor depot 75 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
venorion 75 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
venorion 37.5 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 37.5 mg
venorion 150 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
fluoxetin viatris 20 mg
viatris limited - fluoksetinhydroklorid - kapsel, hard - 20 mg
fenylefrin unimedic 0.05 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.05 mg/ ml
fenylefrin unimedic 0.1 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.1 mg/ ml
brintellix
h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling av alvorlige depressive episoder hos voksne.
xalkori
pfizer europe ma eeig - crizotinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.